Commissioning cranial single-isocenter multi-target radiosurgery for the Versa HD.
Elements Multiple Brain Mets SRS
SRS
Versa HD
Journal
Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
29
01
2021
received:
12
11
2020
accepted:
16
02
2021
pubmed:
24
3
2021
medline:
22
6
2021
entrez:
23
3
2021
Statut:
ppublish
Résumé
Brainlab's Elements Multiple Brain Mets SRS (MBMS) is a dedicated treatment planning system for single-isocenter multi-target (SIMT) cranial stereotactic radiosurgery (SRS) treatments. The purpose of this study is to present the commissioning experience of MBMS on an Elekta Versa HD. MBMS was commissioned for 6 X, 6 FFF, and 10 FFF. Beam data collected included: output factors, percent depth doses (PDDs), diagonal profiles, collimator transmission, and penumbra. Beam data were processed by Brainlab and resulting parameters were entered into the planning system to generate the beam model. Beam model accuracy was verified for simple fields. MBMS plans were created on previously treated cranial SRS patient data sets. Plans were evaluated using Paddick inverse conformity (ICI), gradient indices (GI), and cumulative volume of brain receiving 12 Gy. Dosimetric accuracy of the MBMS plans was verified using microDiamond, Gafchromic film, and SRS Mapcheck measurements of absolute dose and dose profiles for individual targets. Finally, an end-to-end (E2E) test was performed with a MR-CT compatible phantom to validate the accuracy of the simulation-to-delivery process. For square fields, calculated scatter factors were within 1.0% of measured, PDDs were within 0.5% past dmax, and diagonal profiles were within 0.5% for clinically relevant off-axis distances (<10 cm). MBMS produced plans with ICIs < 1.5 and GIs < 5.0 for targets > 10 mm. Average point doses of the MBMS plans, measured by microDiamond, were within 0.31% of calculated (max 2.84%). Average per-field planar pass rates were 98.0% (95.5% minimum) using a 2%/1 mm/10% threshold relative gamma analysis. E2E point dose measurements were within 1.5% of calculated and Gafchromic film pass rates were 99.6% using a 5%/1 mm/10% threshold gamma analysis. The experience presented can be used to aid the commissioning of the Versa HD in the Brainlab MBMS treatment planning system, to produce safe and accurate SIMT cranial SRS treatments.
Identifiants
pubmed: 33756044
doi: 10.1002/acm2.13223
pmc: PMC8035552
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
108-114Informations de copyright
© 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine.
Références
Cureus. 2020 Aug 18;12(8):e9833
pubmed: 32832305
Med Phys. 2019 Feb;46(2):944-963
pubmed: 30521073
Cureus. 2016 Nov 15;8(11):e882
pubmed: 28003946
Med Phys. 2008 Sep;35(9):4186-215
pubmed: 18841871
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):540-6
pubmed: 26460996
Med Phys. 2009 Sep;36(9):4197-212
pubmed: 19810494
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):467-74
pubmed: 21945110
Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1143-8
pubmed: 10725624
Radiat Oncol. 2019 Jun 11;14(1):103
pubmed: 31186023
J Neurosurg. 2000 Dec;93 Suppl 3:219-22
pubmed: 11143252
Med Phys. 2009 Nov;36(11):5359-73
pubmed: 19994544
J Neurosurg. 2015 Aug;123(2):373-86
pubmed: 25978710
Radiother Oncol. 2014 Jul;112(1):128-32
pubmed: 24997990
J Neurosurg. 2006 Dec;105 Suppl:194-201
pubmed: 18503356
Radiat Oncol. 2016 Feb 02;11:13
pubmed: 26831367
J Appl Clin Med Phys. 2016 Jan 08;17(1):179-191
pubmed: 26894351
Med Phys. 2018 Nov;45(11):e1123-e1145
pubmed: 30247757
Med Phys. 1998 Oct;25(10):1773-829
pubmed: 9800687
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):296-302
pubmed: 19836151
Med Phys. 2011 Jul;38(7):4166-73
pubmed: 21859018